Latest Headlines
-
Lucira Health Announces FDA Authorization Of First & Only At-Home Combination Covid-19 & Flu Test And Comments On Chapter 11 Bankruptcy Filing
2/27/2023
Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health" or "Lucira"), a medical technology company, announced today that the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for its Lucira COVID-19 & Flu Home Test for over the counter (OTC) use at home and other non-laboratory sites
-
Sonde Health And MassGen Selected For MassAITC Pilot Study To Examine Use Of Voice In Remote Detection And Monitoring Of Mild Cognitive Impairment
2/27/2023
Sonde Health, a health technology company committed to bringing accessible health monitoring to everyone, in conjunction with the Massachusetts General Hospital (MGH) Frontotemporal Disorders (FTD) Unit, has been selected by the Massachusetts Artificial Intelligence and Technology Center for Connected Care in Aging & Alzheimer’s Disease (MassAITC) to lead a pilot study focused on leveraging vocal biomarkers for remote detection and monitoring of mild cognitive impairment in the home environment.
-
Co-Diagnostics, Inc. Initiates Clinical Evaluations For Its At-Home And Point-Of-Care Co-Dx PCR Home™ Platform
2/22/2023
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has commenced clinical evaluations for its at-home and point-of-care Co-Dx PCR Home™ platform and initial COVID-19 test, consisting of the clinical trials and analytical studies that are expected to support submissions to the United States FDA and other regulatory bodies.
-
Is An AI Platform The Answer To Caring For Japan's Aging Population? Israeli Company Sentercare And Japanese Nozomi MedAlliance Think So
2/21/2023
SenterCare and Nozomi MedAlliance K.K. ("Nozomi") announced today that they have forged an alliance to bring SenterCare's advanced aging-at-home-safely technology to the Japanese market.
-
Improving Access & Timely Care For Vulnerable Patients Referred To Home Health Via Telehealth Physician Support
2/17/2023
AccentCare, a national leader in post-acute care, and Sound Physicians, a leading provider of telehealth and physician services, are excited to release the results of a case-control study that leveraged telehealth during the Public Health Emergency (PHE).
-
Smile Health Orthodontics (SHO) Now Offering At-Home Concierge Orthodontics Solution
2/16/2023
In order to serve the growing number of patients who prefer to receive care in the comfort and convenience of their home, Smile Health Orthodontics is now offering an innovative and exclusive solution: Concierge Orthodontics.
-
Amedisys Partners With BlueCross BlueShield Of Tennessee To Provide Palliative Care At Home To Members
2/15/2023
Today, Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, announced a new agreement with BlueCross BlueShield of Tennessee to provide members in Middle Tennessee with palliative care in the comfort of their homes.
-
HouseWorks Announces Acquisition Of Amedisys’ Personal Care Division
2/15/2023
HouseWorks LLC, a leading provider of personal care services in Massachusetts, New Hampshire, Pennsylvania, and Maine, today announces that is has signed a definitive agreement to acquire the Personal Care division at Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, and high-acuity care.
-
WorldView And Hucu.ai Partner To Better Serve Home Health And Hospice Agencies
2/14/2023
Leading enterprise content management solution WorldView today announced a new collaboration with Hucu.ai, designed to simplify, organize, and automate real-time communication and care coordination for home health and hospice agencies.
-
Monogram Health's In-Home Services Now Available To More Older Adults Living With Chronic Kidney Conditions
2/7/2023
Monogram Health, a specialty provider of in-home, evidence-based care and benefit management services for patients living with polychronic conditions, is now available to Cigna Medicare Advantage customers nationwide.